San Diego-based connected sleep device maker ResMed and Alphabet's life science offshoot Verily announced the formation of Primasun, an end-to-end solution to help employers and healthcare providers identify populations at risk for complex sleep disorders.
Formed as a joint venture, Primasun will initially evaluate patients with insomnia, provide guidance to improve sleep hygiene and connect...
Alphabet's life science offshoot Verily announced it had raised $1 billion in an investment round led by its parent company alongside a shakeup of its executive team.
The company's founder Andy Conrad will step down as CEO, moving to an executive chairman position on Verily's board. Current president Stephen Gillett will take the reins in the chief executive role, effective January 2023.
Gillett...
Alphabet’s life science subsidiary Verily is working to detach itself from Google’s technology and possibly move outside its parent company, according to reporting by Insider.
The plan, internally called Flywheel, launched early this year to remove Verily’s products from Google’s computing infrastructure, as in moving the business unit from Google’s internal cloud service to a public version...
The FDA has rejected Verily's Parkinson's disease-focused clinical trial tool designed to evaluate the effectiveness of certain interventions, on the premise that it has limited ability to capture the full picture of a patient's capacities.
The tool, dubbed the Virtual Motor Exam for Parkinson's disease, runs on the FDA-cleared Verily Study Watch and was designed to digitally assess a patient's...
Kidney care company Strive Health landed $140 million in a Series B funding led by Alphabet’s growth fund CapitalG, bringing its total funding to $223.5 million. The deal is expected to give the company “unique access” to Google and Alphabet assets.
Redpoint, NEA, Town Hall Ventures, Ascension Ventures and Echo Ventures also participated in the round.
WHAT IT DOES
The company’s platform is able...
Google Health has announced a new wellness feature coming to its Google Fit mobile app that uses machine learning to give users heart rate and respiratory rate readings without the need for any hardware other than their smartphone's camera.
The two tools are slated to launch for all Pixel devices in the next month, and will come to additional Android devices running version 6 within the months to...
Fourteen-and-a-half months later, Google has finally completed its acquisition of health wearables company Fitbit. The news was announced this morning in complementary statements from Fitbit cofounder and (now previous) CEO James Park and Rick Osterloh, Google's SVP of devices and services.
"This is just the beginning because becoming part of the Google family means we can do even more to inspire...
Considering the size and scope of Alphabet, it should be little surprise that the company and its subsidiaries (Google, Google Cloud and Verily, to name a few) have become deeply ingrained in the healthcare ecosystem over the last several years.
The tech giant maintained the momentum in 2020 with efforts focused on artificial intelligence, data flow and digital clinical research – and also sought...
Alphabet’s life sciences and healthcare subsidiary Verily has raised $700 million in an investment round funded by its existing investors, including Alphabet, Silver Lake, Temasek, Ontario Teachers’ Pension Plan and others.
WHAT IT DOES
Verily serves as Alphabet’s research arm that develops tools and devices to collect, organize and activate health data. It also creates interventions to prevent...
Following months of regulatory investigation, the European Commission has officially signed off on Google's $2.1 billion purchase of health-wearable-maker Fitbit. Still, the go-ahead is contingent on a handful of commitments from the tech company that focus on its competitive practices across advertising, digital health APIs and smart device interoperability.
"We can approve the proposed...
